MIAMI BEACH, Fla., July 16, 2024 /PRNewswire/ -- ShiraTronics, a trailblazing clinical-stage neurostimulation company, proudly presented findings from its Australian Pilot Study, RELIEV-CM, at the ...
MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ -- ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced ...
MINNEAPOLIS, Dec. 19, 2023 /PRNewswire/ -- ShiraTronics, Inc., a trailblazing clinical-stage medical device company, today announced a landmark achievement with the successful implantation of its ...
ShiraTronics Unveils Data on their Neurostimulation System for Chronic Migraine | | news-journal.com
MIAMI BEACH, Fla., July 16, 2024 /PRNewswire/ -- ShiraTronics, a trailblazing clinical-stage neurostimulation company, proudly presented findings from its Australian Pilot Study, RELIEV-CM, at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback